Knight Robert Douglas 4
4 · NexImmune, Inc. · Filed Apr 7, 2022
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Knight Robert Douglas
Chief Medical Officer
Transactions
- Award
Stock Options (Right to Buy)
2022-04-05+48,000→ 48,000 totalExercise: $4.22Exp: 2032-04-04→ Common Stock (48,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Knight's continued service to the corporation on each vesting date.